Zeitschriftenartikel zum Thema „GB recurrence“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "GB recurrence" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Stadlbauer, Andreas, Ilker Eyüpoglu, Michael Buchfelder, Arnd Dörfler, Max Zimmermann, Gertraud Heinz und Stefan Oberndorfer. „Vascular architecture mapping for early detection of glioblastoma recurrence“. Neurosurgical Focus 47, Nr. 6 (Dezember 2019): E14. http://dx.doi.org/10.3171/2019.9.focus19613.
Der volle Inhalt der QuelleStadlbauer, Andreas, Stefan Oberndorfer, Max Zimmermann, Bertold Renner, Michael Buchfelder, Gertraud Heinz, Arnd Doerfler, Andrea Kleindienst und Karl Roessler. „Physiologic MR imaging of the tumor microenvironment revealed switching of metabolic phenotype upon recurrence of glioblastoma in humans“. Journal of Cerebral Blood Flow & Metabolism 40, Nr. 3 (07.02.2019): 528–38. http://dx.doi.org/10.1177/0271678x19827885.
Der volle Inhalt der QuelleLessi, F., M. Morelli, P. Aretini, M. Menicagli, S. Franceschi, F. Pasqualetti, C. Gambacciani, A. Di Stefano, O. Santonocito und C. M. Mazzanti. „P14.01.B Isolation and characterization of circulating tumor cells in a glioblastoma case with recurrence at distance and correlation with tumor mutational status“. Neuro-Oncology 24, Supplement_2 (01.09.2022): ii82. http://dx.doi.org/10.1093/neuonc/noac174.286.
Der volle Inhalt der QuelleBeppu, Takaaki, Yuichi Sato, Toshiaki Sasaki, Kazunori Terasaki und Kuniaki Ogasawara. „NI-19 Use of 11C-methionine PET for decision of discontinuation of adjuvant chemotherapy with temozolomide“. Neuro-Oncology Advances 2, Supplement_3 (01.11.2020): ii14. http://dx.doi.org/10.1093/noajnl/vdaa143.062.
Der volle Inhalt der QuellePettiwala, Aafrin M., Cathy Pichol-Thievend, Oceane Anezo, Guillaume Bourmeau, Remi Montagne, Anne-Marie Lyne, Pierre-Olivier Guichet Guichet et al. „TMIC-76. GLIOBLASTOMA VESSEL CO-OPTION OCCURS AS A RESISTANCE MECHANISM TO CHEMORADIATION VIA INDUCTION OF A NOVEL CELL STATE“. Neuro-Oncology 25, Supplement_5 (01.11.2023): v295. http://dx.doi.org/10.1093/neuonc/noad179.1141.
Der volle Inhalt der QuelleLee, Jae-Myeong, Bong-Wan Kim, Wook Hwan Kim, Hee-Jung Wang und Myung Wook Kim. „Clinical Implication of Bile Spillage in Patients Undergoing Laparoscopic Cholecystectomy for Gallbladder Cancer“. American Surgeon 77, Nr. 6 (Juni 2011): 697–701. http://dx.doi.org/10.1177/000313481107700623.
Der volle Inhalt der QuelleBelokon, S. V., I. A. Gulidov, D. V. Gogolin, K. E. Medvedeva, S. A. Ivanov und A. D. Kaprin. „Re-irradiation combined with bevacizumab in the treatment of glioblastoma recurrence“. Siberian journal of oncology 23, Nr. 1 (21.03.2024): 142–54. http://dx.doi.org/10.21294/1814-4861-2024-23-1-142-154.
Der volle Inhalt der QuelleCianci, Francesca, Guido Rey, Dietmar Krex, Davide Ceresa, Paolo Malatesta und Michele Mazzanti. „Abstract 2092: Genomic and proteomic analysis of glioblastoma recurrences during TTFields exposure“. Cancer Research 84, Nr. 6_Supplement (22.03.2024): 2092. http://dx.doi.org/10.1158/1538-7445.am2024-2092.
Der volle Inhalt der QuelleSimionescu, Natalia, Miruna Nemecz, Anca-Roxana Petrovici, Ioan Sebastian Nechifor, Razvan-Cristian Buga, Marius Gabriel Dabija, Lucian Eva und Adriana Georgescu. „Microvesicles and Microvesicle-Associated microRNAs Reflect Glioblastoma Regression: Microvesicle-Associated miR-625-5p Has Biomarker Potential“. International Journal of Molecular Sciences 23, Nr. 15 (29.07.2022): 8398. http://dx.doi.org/10.3390/ijms23158398.
Der volle Inhalt der QuelleNakao, Sayumi, Michio Itabashi, Mamiko Ubukata, Yoshiko Bamba, Tomoichiro Hirosawa, Shimpei Ogawa, Shingo Kameoka und Kenichi Sugihara. „Age-specific prognostic factors in patients treated surgically for pulmonary metastases of colorectal cancer: A multi-institutional cumulative follow-up study.“ Journal of Clinical Oncology 33, Nr. 3_suppl (20.01.2015): 773. http://dx.doi.org/10.1200/jco.2015.33.3_suppl.773.
Der volle Inhalt der QuellePichol-Thievend, C., O. Anezo, A. M. Pettiwala, G. Bourmeau, R. Montagne, A. Lyne, P. Guichet et al. „OS07.5.A GLIOBLASTOMA VESSEL CO-OPTION AND TRANSITION TO A RESISTANT CELL STATE ARE INDUCED BY CHEMORADIATION“. Neuro-Oncology 25, Supplement_2 (01.09.2023): ii18. http://dx.doi.org/10.1093/neuonc/noad137.052.
Der volle Inhalt der QuelleTan, David, Imogen Roth, Agadha Wickremesekera, Paul Davis, Andrew Kaye, Theo Mantamadiotis, Stanley Stylli und Swee Tan. „Therapeutic Targeting of Cancer Stem Cells in Human Glioblastoma by Manipulating the Renin-Angiotensin System“. Cells 8, Nr. 11 (31.10.2019): 1364. http://dx.doi.org/10.3390/cells8111364.
Der volle Inhalt der QuelleCentonze, Giovanni, Alessandro Mangogna, Tiziana Salviato, Beatrice Belmonte, Laura Cattaneo, Melissa Anna Teresa Monica, Giovanna Garzone et al. „Gastroblastoma in Adulthood—A Rarity among Rare Cancers—A Case Report and Review of the Literature“. Case Reports in Pathology 2019 (28.11.2019): 1–6. http://dx.doi.org/10.1155/2019/4084196.
Der volle Inhalt der QuelleObrador, Elena, Paz Moreno-Murciano, María Oriol-Caballo, Rafael López-Blanch, Begoña Pineda, Julia Lara Gutiérrez-Arroyo, Alba Loras et al. „Glioblastoma Therapy: Past, Present and Future“. International Journal of Molecular Sciences 25, Nr. 5 (21.02.2024): 2529. http://dx.doi.org/10.3390/ijms25052529.
Der volle Inhalt der QuelleChirica, Costin, Danisia Haba, Elena Cojocaru, Andreea Isabela Mazga, Lucian Eva, Bogdan Ionut Dobrovat, Sabina Ioana Chirica, Ioana Stirban, Andreea Rotundu und Maria Magdalena Leon. „One Step Forward—The Current Role of Artificial Intelligence in Glioblastoma Imaging“. Life 13, Nr. 7 (14.07.2023): 1561. http://dx.doi.org/10.3390/life13071561.
Der volle Inhalt der QuelleO’Rawe, Michael, Ethan J. Kilmister, Theo Mantamadiotis, Andrew H. Kaye, Swee T. Tan und Agadha C. Wickremesekera. „The Renin–Angiotensin System in the Tumor Microenvironment of Glioblastoma“. Cancers 13, Nr. 16 (09.08.2021): 4004. http://dx.doi.org/10.3390/cancers13164004.
Der volle Inhalt der QuelleHamza, Mohamed Ali, Jacob Mandel, Charles A. Conrad, Mark R. Gilbert, W. K. Alfred Yung, Vinay K. Puduvalli und John Frederick De Groot. „Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.“ Journal of Clinical Oncology 31, Nr. 15_suppl (20.05.2013): 2042. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.2042.
Der volle Inhalt der QuelleChédeville, Agathe L., und Patricia A. Madureira. „The Role of Hypoxia in Glioblastoma Radiotherapy Resistance“. Cancers 13, Nr. 3 (01.02.2021): 542. http://dx.doi.org/10.3390/cancers13030542.
Der volle Inhalt der QuelleStephenson, Connor, Daniel G. McDonald, Milad Yazdani, Shikhar Mehrotra, Cynthia A. Welsh, Libby Kosnik Infinger, William A. Vandergrift et al. „NIMG-78. DEVELOPMENT OF A PRECLINICAL GLIOBLASTOMA MURINE MODEL FOR THE ASSESSMENT OF RADIATION NECROSIS USING DIFFUSION KURTOSIS IMAGING“. Neuro-Oncology 24, Supplement_7 (01.11.2022): vii183. http://dx.doi.org/10.1093/neuonc/noac209.696.
Der volle Inhalt der QuelleAntipina, N., A. Belyashova, G. Pavlova, A. Nikolaeva, E. Savchenko, A. Ovechkina, D. Shamadykova und A. Golanov. „P02.02 Modeling of response to irradiation in recurrence glioblastoma’s cells culture“. Neuro-Oncology 23, Supplement_2 (01.09.2021): ii17. http://dx.doi.org/10.1093/neuonc/noab180.055.
Der volle Inhalt der QuelleAkhunbay-Fudge, Christopher Yusuf, Kevin Critchley, Ryan Mathew und Heiko Wurdak. „CCRG-04. AUTOMATED REAL TIME TRACKING OF GLIOBLASTOMA CELL CYCLE TRANSITIONS IN ASSEMBLOIDS LINKS G2 CELLS TO INFILTRATION“. Neuro-Oncology 25, Supplement_5 (01.11.2023): v39. http://dx.doi.org/10.1093/neuonc/noad179.0153.
Der volle Inhalt der QuelleWang, Xiaowen, Matias Bustos, Xiaoqing Zhang, Romela Ramos, Cong Tan, Yuuki Iida, Shu-Ching Chang et al. „Downregulation of the Ubiquitin-E3 Ligase RNF123 Promotes Upregulation of the NF-κB1 Target SerpinE1 in Aggressive Glioblastoma Tumors“. Cancers 12, Nr. 5 (27.04.2020): 1081. http://dx.doi.org/10.3390/cancers12051081.
Der volle Inhalt der QuelleLessi, Francesca, Sara Franceschi, Mariangela Morelli, Michele Menicagli, Francesco Pasqualetti, Orazio Santonocito, Carlo Gambacciani et al. „Single-Cell Molecular Characterization to Partition the Human Glioblastoma Tumor Microenvironment Genetic Background“. Cells 11, Nr. 7 (26.03.2022): 1127. http://dx.doi.org/10.3390/cells11071127.
Der volle Inhalt der QuelleAttia, Noha, Mohamed Mashal, Sudhakar Pemminati, Adekunle Omole, Carolyn Edmondson, Will Jones, Priyanka Priyadarshini et al. „Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies“. Cells 11, Nr. 1 (30.12.2021): 116. http://dx.doi.org/10.3390/cells11010116.
Der volle Inhalt der QuellePatrón, Lilian A., Helen Yeoman, Sydney Wilson, Nanyun Tang, Michael E. Berens, Vijay Gokhale und Teri C. Suzuki. „Novel Brain-Penetrant, Small-Molecule Tubulin Destabilizers for the Treatment of Glioblastoma“. Biomedicines 12, Nr. 2 (09.02.2024): 406. http://dx.doi.org/10.3390/biomedicines12020406.
Der volle Inhalt der QuelleComas Antón, S., S. Moreno, M. Antelo, C. Carrato, C. Balaña, S. Castañer, A. Hernández, C. Hostalot, M. Domenech und S. Villà. „P11.30.A LONG-TERM SURVIVING GLIOBLASTOMA. CLINICAL, MOLECULAR AND SURVIVAL ANALYSES“. Neuro-Oncology 25, Supplement_2 (01.09.2023): ii80. http://dx.doi.org/10.1093/neuonc/noad137.264.
Der volle Inhalt der QuelleBourmeau, G., O. Anezo, A. Ballestin, C. Pichol-Thievend, J. Reveilles und G. Seano. „OS07.7.A GLIOBLASTOMA HYBRID CELL STATE CONVEYS RESISTANCE TO CONVENTIONAL THERAPIES“. Neuro-Oncology 25, Supplement_2 (01.09.2023): ii18—ii19. http://dx.doi.org/10.1093/neuonc/noad137.054.
Der volle Inhalt der QuelleMorelli, M., F. Lessi, M. Giacomarra, A. Marranci, M. Menicagli, O. S. Santonocito, P. Aretini et al. „P17.16.B INVESTIGATION OF REGORAFENIB TUMOR SENSITIVITY AND UNDERLYING TREATMENT INDUCED MOLECULAR MECHANISMS IN GLIOBLASTOMA RECURRENT TUMORS“. Neuro-Oncology 25, Supplement_2 (01.09.2023): ii120—ii121. http://dx.doi.org/10.1093/neuonc/noad137.406.
Der volle Inhalt der QuelleLin, Chao-Qun, und Lu-Kui Chen. „Effect of differential hypoxia-related gene expression on glioblastoma“. Journal of International Medical Research 49, Nr. 5 (Mai 2021): 030006052110137. http://dx.doi.org/10.1177/03000605211013774.
Der volle Inhalt der QuelleZimmer, Niklas, Emily R. Trzeciak, Andreas Müller, Philipp Licht, Bettina Sprang, Petra Leukel, Volker Mailänder et al. „Nuclear Glycoprotein A Repetitions Predominant (GARP) Is a Common Trait of Glioblastoma Stem-like Cells and Correlates with Poor Survival in Glioblastoma Patients“. Cancers 15, Nr. 24 (05.12.2023): 5711. http://dx.doi.org/10.3390/cancers15245711.
Der volle Inhalt der QuelleCardoso, Ana M., Catarina M. Morais, Frederico Pena, Tânia Marante, Pedro P. Cunha, Amália S. Jurado und Maria C. Pedroso de Lima. „Differentiation of glioblastoma stem cells promoted by miR-128 or miR-302a overexpression enhances senescence-associated cytotoxicity of axitinib“. Human Molecular Genetics 30, Nr. 3-4 (12.01.2021): 160–71. http://dx.doi.org/10.1093/hmg/ddab011.
Der volle Inhalt der QuelleLucas Calduch, A., M. Macià Garau, S. Villà Freixa, G. Plans Ahicart, C. Mesía Barroso, C. Majós Torró, A. Pons Escoda et al. „P17.09.B REIRRADIATION AS A SALVAGE THERAPY FOR LOCAL GLIOBLASTOMA RECURRENCE“. Neuro-Oncology 25, Supplement_2 (01.09.2023): ii118—ii119. http://dx.doi.org/10.1093/neuonc/noad137.399.
Der volle Inhalt der QuelleClavreul, Anne, Lila Autier, Jean-Michel Lemée, Paule Augereau, Gwénaëlle Soulard, Luc Bauchet, Dominique Figarella-Branger, Philippe Menei und FGB Network. „Management of Recurrent Glioblastomas: What Can We Learn from the French Glioblastoma Biobank?“ Cancers 14, Nr. 22 (09.11.2022): 5510. http://dx.doi.org/10.3390/cancers14225510.
Der volle Inhalt der QuelleVilarino, Noelia, Neus Martinez-Bosch, Carmen Balana, Francesc Alameda, Anna Estival, Estela Pineda, Sonia del Barco et al. „Galectin-1 (Gal-1) expression as a prognostic factor in patients with newly diagnosed glioblastoma (GB) treated with Stupp regimen (GLIOCAT study).“ Journal of Clinical Oncology 35, Nr. 15_suppl (20.05.2017): e13526-e13526. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e13526.
Der volle Inhalt der QuelleLee, Sang Hun, Yong Mi Seol und Dong Uk Kim. „Preoperative risk factors related to relapse-free survival after R0 resection of gallbladder cancer.“ Journal of Clinical Oncology 42, Nr. 3_suppl (20.01.2024): 566. http://dx.doi.org/10.1200/jco.2024.42.3_suppl.566.
Der volle Inhalt der QuelleBynoe, Margaret S. „Glioblastoma usurps host extracellular adenosine to circumvent host anti-tumor Responses“. Journal of Immunology 198, Nr. 1_Supplement (01.05.2017): 76.17. http://dx.doi.org/10.4049/jimmunol.198.supp.76.17.
Der volle Inhalt der QuelleHervás-Corpión, Irati, Jorge Navarro-Calvo, Paula Martín-Climent, Marianela Iriarte-Gahete, Noelia Geribaldi-Doldán, Carmen Castro und Luis M. Valor. „Defining a Correlative Transcriptional Signature Associated with Bulk Histone H3 Acetylation Levels in Adult Glioblastomas“. Cells 12, Nr. 3 (19.01.2023): 374. http://dx.doi.org/10.3390/cells12030374.
Der volle Inhalt der QuelleSun, Xuheng, Yijun WANG und Yingbin Liu. „Construction and validation of the prognostic model for patients with gallbladder neuroendocrine neoplasm-based a nationwide retrospective registry study.“ Journal of Clinical Oncology 40, Nr. 16_suppl (01.06.2022): e16140-e16140. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e16140.
Der volle Inhalt der QuelleTodkar, Sampatti Sambhaji, und Lagdir Appasaheb Gaikwad. „Outcome of suspected H1N1 influenza cases admitted in tertiary care Govt. Hospital Solapur, Maharashtra“. Indian Journal of Medical Sciences 69, Nr. 1 (28.03.2017): 6. http://dx.doi.org/10.18203/issn.0019-5359.indianjmedsci20170482.
Der volle Inhalt der QuelleMann, Anmol, Nur Safa, Emma Martell, Wenxia Luo, Prasanta Paul, Parandoush Abbasian, Rashid Ahmed et al. „BSCI-07 ACETYL-AMANTADINE AS A DIAGNOSTIC BIOMARKER IN PATIENTS WITH GLIOBLASTOMA“. Neuro-Oncology Advances 4, Supplement_1 (01.08.2022): i2. http://dx.doi.org/10.1093/noajnl/vdac078.007.
Der volle Inhalt der QuelleSokolov, Dmitry K., Oleg B. Shevelev, Anna S. Khotskina, Alexandra Y. Tsidulko, Anastasia V. Strokotova, Galina M. Kazanskaya, Alexander M. Volkov et al. „Dexamethasone Inhibits Heparan Sulfate Biosynthetic System and Decreases Heparan Sulfate Content in Orthotopic Glioblastoma Tumors in Mice“. International Journal of Molecular Sciences 24, Nr. 12 (16.06.2023): 10243. http://dx.doi.org/10.3390/ijms241210243.
Der volle Inhalt der QuelleKurz, Sabine K., und Matthias J. Reddehase. „Patchwork Pattern of Transcriptional Reactivation in the Lungs Indicates Sequential Checkpoints in the Transition from Murine Cytomegalovirus Latency to Recurrence“. Journal of Virology 73, Nr. 10 (01.10.1999): 8612–22. http://dx.doi.org/10.1128/jvi.73.10.8612-8622.1999.
Der volle Inhalt der QuelleChernov, Alexandr, Irina Baldueva, Tatyana Nekhaeva, Elvira Galimova, Diana Alaverdian und Olga Shamova. „The molecular mechanisms of multidrug resistance of human glioblastomas“. Problems in oncology 67, Nr. 1 (04.03.2021): 20–28. http://dx.doi.org/10.37469/0507-3758-2021-67-1-20-28.
Der volle Inhalt der QuelleMendes, Maria, João José Sousa, Alberto Pais und Carla Vitorino. „Targeted Theranostic Nanoparticles for Brain Tumor Treatment“. Pharmaceutics 10, Nr. 4 (09.10.2018): 181. http://dx.doi.org/10.3390/pharmaceutics10040181.
Der volle Inhalt der QuelleBallestín, A., C. Pichol-Thievend, G. Bourmeau, B. Blanchard, A. Pettiwala, J. Reveilles, S. Leboucher, O. Anezo und G. Seano. „P10.20.B POSTOPERATIVE ISCHEMIA CAUSED BY MICROSURGICAL RESECTION PROMOTES PRONEURAL-TO-MESENCHYMAL TRANSITION IN GLIOBLASTOMA“. Neuro-Oncology 25, Supplement_2 (01.09.2023): ii66—ii67. http://dx.doi.org/10.1093/neuonc/noad137.218.
Der volle Inhalt der QuelleGiordano, Carolina, Giuseppe Maria Della Pepa, Simona Romano, Laura Marrone, Carlo Maria Donzelli, Maria Fiammetta Romano und Simona Gaudino. „Abstract 5474: Combined use of MRI and TAM analysis in GB monitoring“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 5474. http://dx.doi.org/10.1158/1538-7445.am2023-5474.
Der volle Inhalt der QuelleAntelo, G., I. Valduvieco, S. Comas, S. Serrano, J. Molero, C. Balañá, S. Villà, S. Moreno, M. Mollà und C. Gomà. „P11.36.A Could a transcriptome profile predict local control for glioblastoma?“ Neuro-Oncology 24, Supplement_2 (01.09.2022): ii65. http://dx.doi.org/10.1093/neuonc/noac174.225.
Der volle Inhalt der QuelleFan, Qing Qing, He Li und Hong Xi Yin. „Study on Optical Performance Monitoring for Fiber-Optical Link Utilizing Chaos Theory“. Advanced Materials Research 571 (September 2012): 390–94. http://dx.doi.org/10.4028/www.scientific.net/amr.571.390.
Der volle Inhalt der QuelleHumphreys, Luke M., Paul Smith, Zhuoyao Chen, Shahd Fouad und Vincenzo D’Angiolella. „The role of E3 ubiquitin ligases in the development and progression of glioblastoma“. Cell Death & Differentiation 28, Nr. 2 (11.01.2021): 522–37. http://dx.doi.org/10.1038/s41418-020-00696-6.
Der volle Inhalt der QuelleHelaine, Charly, Aurélie E. Ferré, Marine M. Leblond, Elodie A. Pérès, Myriam Bernaudin, Samuel Valable und Edwige Petit. „Angiopoietin-2 Combined with Radiochemotherapy Impedes Glioblastoma Recurrence by Acting in an Autocrine and Paracrine Manner: A Preclinical Study“. Cancers 12, Nr. 12 (30.11.2020): 3585. http://dx.doi.org/10.3390/cancers12123585.
Der volle Inhalt der Quelle